Fenoflick 145 Tablet contains Fenofibrate 145mg, a lipid-lowering agent used for management of high cholesterol, elevated triglycerides, and mixed dyslipidemia. It helps reduce cardiovascular risk in patients with lipid disorders.
Fenofibrate works by activating peroxisome proliferator-activated receptor alpha (PPARα), which increases lipid metabolism, reduces triglycerides, and improves HDL cholesterol levels. This mechanism supports overall cardiovascular health.
This tablet is commonly prescribed for patients with hyperlipidemia, mixed dyslipidemia, or metabolic syndrome, providing effective lipid control and long-term prevention of cardiovascular events.
Fenoflick 145 Tablet is valued for its efficacy, clinical reliability, and high prescription demand, making it a trusted option in cardiac care. Its role in managing cholesterol and triglycerides supports heart health and enhances patient adherence in chronic therapy regimens.